AP-HP Greater Paris University Hospital, Psychiatry Department, University Hospital Louis Mourier, France; University of Paris, INSERM UMR1266, Institute of Psychiatry and Neurosciences of Paris (IPNP), Paris, France.
AP-HP Greater Paris University Hospital, Psychiatry Department, University Hospital Louis Mourier, France.
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109988. doi: 10.1016/j.pnpbp.2020.109988. Epub 2020 May 29.
Negative Symptoms (blunted affect, alogia, anhedonia, avolition, and asociality) are usually described in schizophrenia but they are also present in other psychiatric disorders. The diagnosis and prognosis relevance of negative symptoms (NS) self-assessment during a first psychiatric episode is still unknown.
To determine (i) the rate of self-assessed NS in a first psychiatric episode among adolescents and young adults compared to control subjects; and (ii), whether there is a difference in the prevalence of NS between schizophrenia and major depressive disorder first episodes.
The population included patients aged 15-25 years, with no psychiatric history and no history of medication. A dimensional evaluation was assessed during hospitalization, including depressive (Hamilton Depression Scale), psychotic symptoms (Prodromal Questionnaire, 16 items) and the self-evaluation of negative symptoms (SNS scale). Prospective categorical diagnoses were updated 6 months after hospitalization. The population included 117 individuals (58 patients and 59 healthy controls).
Among healthy individuals, 47.5% reported at least one NS, the most reported being amotivation. After binary logistic regression, Negative Symptoms (SNS score) were associated with a diagnostic of psychiatric disorder at the 6-months follow-up (OR = 1.163, p = .001), whereas depressive symptoms and psychotic experiences were not. A SNS threshold allowed to screen first episode patients and SZ patients in the general population (assessed with ROC curve). A high prevalence of self-reported NS was observed across diagnostic boundaries in first psychiatric episodes, with a mean SNS score of 19.3 ± 7.1 for schizophrenic disorders and 20.7 ± 8.6 for depressive disorders. The prevalence of NS was not significantly different between depressive disorders and schizophrenic disorders (p > .05).
NS are an important transnosographic dimension during first psychiatric episodes among adolescents and young adults. Negative symptoms self-assessment with the SNS scale is relevant during a first psychiatric episode.
阴性症状(情感迟钝、言语贫乏、快感缺失、意志减退和社会性退缩)通常在精神分裂症中描述,但也存在于其他精神障碍中。在首次精神病发作期间,阴性症状(NS)自我评估的诊断和预后相关性尚不清楚。
确定(i)与对照组相比,青少年和年轻成年人首次精神病发作时自我评估的 NS 发生率;以及(ii)精神分裂症和首发重性抑郁障碍之间 NS 的患病率是否存在差异。
该人群包括年龄在 15-25 岁之间、无精神病史且无用药史的患者。在住院期间进行了维度评估,包括抑郁(汉密尔顿抑郁量表)、精神病症状(前驱症状问卷,16 项)和阴性症状自我评估(SNS 量表)。住院 6 个月后更新前瞻性分类诊断。该人群包括 117 名个体(58 名患者和 59 名健康对照者)。
在健康个体中,有 47.5%报告至少有一种 NS,报告最多的是动机缺乏。经过二元逻辑回归,阴性症状(SNS 评分)与 6 个月随访时的精神障碍诊断相关(OR=1.163,p=0.001),而抑郁症状和精神病体验则不然。SNS 阈值可用于在普通人群中筛选首发精神病患者和 SZ 患者(通过 ROC 曲线评估)。首次精神病发作时,自我报告的 NS 发生率跨越诊断界限,精神分裂症障碍的平均 SNS 评分为 19.3±7.1,抑郁障碍的平均 SNS 评分为 20.7±8.6。抑郁障碍和精神分裂症障碍的 NS 患病率无显著差异(p>0.05)。
在青少年和年轻成年人首次精神病发作期间,NS 是一个重要的跨疾病维度。在首次精神病发作期间,使用 SNS 量表进行阴性症状自我评估具有重要意义。